Pancreatic Cancer Research

ResearcherCentre National de la Recherche ScientifiqueActive in the last 2 years

Eric Mas

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8925-9195; OpenAlex author ID A5032778149. Sources: OpenAlex.

Their work

Papers
7 (first author 0, last author 4)
Trials
0
Grants
0
Labs led
1
Collaborators
26
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: 2 papers · 2019: 1 paper · 2020: none · 2021: 1 paper · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 7

  1. Co-translational O-glycosylation driven by GALNTs spatial reprogramming fosters pancreatic cancer growth Co-author DOI 10.64898/2026.09.04.749345↗
  2. A glycosyltransferase gene signature to detect pancreatic ductal adenocarcinoma patients with poor prognosis. Last author DOI 10.1016/j.ebiom.2021.103541↗
  3. Deciphering the Crosstalk Between Myeloid-Derived Suppressor Cells and Regulatory T Cells in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3389/fimmu.2019.03070↗
  4. Dendritic cell-based vaccination: powerful resources of immature dendritic cells against pancreatic adenocarcinoma. Co-author DOI 10.1080/2162402x.2018.1504727↗
  5. Pancreatic adenocarcinoma, chronic pancreatitis, and MODY-8 diabetes: is bile salt-dependent lipase (or carboxyl ester lipase) at the crossroads of pancreatic … Last author DOI 10.18632/oncotarget.23619↗
  6. Further characterization of HDAC and SIRT gene expression patterns in pancreatic cancer and their relation to disease outcome. Last author DOI 10.1371/journal.pone.0108520↗
  7. Investigation of a new tumor-associated glycosylated antigen as target for dendritic cell vaccination in pancreatic cancer. Last author DOI 10.4161/onci.1.1.18459↗

Closest collaborators

The 25 strongest of 26 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Nelson Dusetti · 2 shared papers, 2021–2026 · strength 0.36
  2. Dominique Lombardo · 5 shared papers, 2012–2019 · strength 0.32
  3. Richard Tomasini · 2 shared papers, 2018–2026 · strength 0.31
  4. Aurélie Collignon · 4 shared papers, 2012–2019 · strength 0.29
  5. Juan Iovanna · 3 shared papers, 2014–2021 · strength 0.24
  6. Fabienne Guillaumond · 1 shared paper, 2026 · strength 0.24
  7. Sophie Vasseur · 1 shared paper, 2026 · strength 0.24
  8. Rebecca Bennion · 1 shared paper, 2026 · strength 0.24
  9. Frédéric Bard · 1 shared paper, 2026 · strength 0.24
  10. Brice Chanez · 1 shared paper, 2026 · strength 0.24
  11. Martin James Humphries · 1 shared paper, 2026 · strength 0.24
  12. Evelyne Béraud · 3 shared papers, 2012–2018 · strength 0.20
  13. Yousra Mohamed Abd-El-Halim · 1 shared paper, 2021 · strength 0.12
  14. Julie Roques · 1 shared paper, 2021 · strength 0.12
  15. Rémy Nicolle · 1 shared paper, 2021 · strength 0.12
  16. Jerome F. Cros · 1 shared paper, 2021 · strength 0.12
  17. Abdessamad El Kaoutari · 1 shared paper, 2021 · strength 0.12
  18. Carole Siret · 1 shared paper, 2019 · strength 0.09
  19. Աննա Մարտիրոսյան · 1 shared paper, 2019 · strength 0.09
  20. Frederic André · 1 shared paper, 2018 · strength 0.07
  21. Jérémy Nigri · 1 shared paper, 2018 · strength 0.07
  22. Daniel Olive Directeur · 1 shared paper, 2012 · strength 0.04
  23. Céline Loncle · 1 shared paper, 2014 · strength 0.03
  24. Ali Ouaissi · 1 shared paper, 2014 · strength 0.03
  25. Igor Sielezneff · 1 shared paper, 2014 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.